Corcept Therapeutics Incorporated
CORT
$71.38
$0.921.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.17% | -34.88% | 33.04% | 27.83% | -11.46% |
| Total Depreciation and Amortization | 0.43% | -7.82% | 152.02% | 10.61% | -34.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.15% | 645.26% | -10.79% | -155.11% | -47.92% |
| Change in Net Operating Assets | -228.63% | -38.24% | 286.09% | 198.14% | 76.79% |
| Cash from Operations | -91.35% | -19.68% | 79.27% | 73.35% | 303.53% |
| Capital Expenditure | 14.05% | 92.60% | -293.03% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.23% | -51.50% | 29.07% | -563.17% | -152.72% |
| Cash from Investing | 95.07% | -46.15% | 26.84% | -567.78% | -152.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 42.71% | 6.70% | -29.90% | 91.65% | -4.09% |
| Repurchase of Common Stock | -519.30% | 70.10% | -333.66% | -141.35% | -124.32% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -772.11% | 78.36% | -881.02% | -295.95% | -170.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -293.25% | -210.61% | 141.12% | -249.04% | -40.22% |